|Articles|February 1, 2005
Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca
Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Violence against women and children reported a top global health risk
2
Cannabidiol and THC show synergistic anti-cancer effects in ovarian cancer cell models
3
Tiny Tim: Can you guess the diagnosis?
4
Joshua Hare, MD, FAAC, highlights stem cell therapy for female sexual dysfunction
5







